Last update 01 Nov 2024
Somatostatin(BCN Peptides SA)
Last update 01 Nov 2024
Overview
Basic Info
Drug Type Synthetic peptide |
Synonyms Somatostatin |
Mechanism SSTR1 agonists(Somatostatin receptor 1 agonists), SSTR2 agonists(Somatostatin receptor 2 agonists), SSTR3 agonists(Somatostatin receptor 3 agonists) + [2] |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure
Molecular FormulaC76H104N18O19S2 |
InChIKeyNHXLMOGPVYXJNR-ATOGVRKGSA-N |
CAS Registry38916-34-6 |
Related
2
Clinical Trials associated with Somatostatin(BCN Peptides SA)A multicentric, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of COLIRIOBCN070660 administered topically in patients with moderately severe to severe non-proliferative diabetic retinopathy - RETISOM
Neurodegeneration as Early Event in Pathogenesis of Diabetic Retinopathy:Multicentric, Prospective, Ph. II-III,Random.Controlled Trial to Assess Efficacy of Neuroprotective Drugs Administered Topically to Prevent/Arrest Diabetic Retinopathy
100 Clinical Results associated with Somatostatin(BCN Peptides SA)
Login to view more data
100 Translational Medicine associated with Somatostatin(BCN Peptides SA)
Login to view more data
100 Patents (Medical) associated with Somatostatin(BCN Peptides SA)
Login to view more data
100 Deals associated with Somatostatin(BCN Peptides SA)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D07431 | Somatostatin(BCN Peptides SA) |
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetic Retinopathy | Phase 3 | GB | 01 Feb 2013 | |
| Diabetic Retinopathy | Phase 3 | IT | 01 Feb 2013 | |
| Diabetic Retinopathy | Phase 3 | FR | 01 Feb 2013 | |
| Diabetic Retinopathy | Phase 3 | DE | 01 Feb 2013 | |
| Diabetic Retinopathy | Phase 3 | DK | 01 Feb 2013 | |
| Diabetic Retinopathy | Phase 3 | PT | 01 Feb 2013 | |
| Diabetic Retinopathy | Phase 3 | ES | 01 Feb 2013 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free